Portevo
US Companies
MRKNew York Stock Exchange

Merck (MRK) Earnings

Merck's earnings release dates, analyst consensus, and share price reactions to past earnings—all in one place, in English.

Updated: October 11, 2026

Share Price
145.60 USD
+2.26%
Market Cap
$359.22 bn
Next Report
October 29, 2026
confirmed date
Earnings Beat
100%
out of 4 last quarters
Average Share Price Movement
1.65%
on the session after publication
P/E Ratio
115.56
Merck's Earnings Beat RateThe company beat analyst forecasts in 100% of the last 4 quarters.100%above forecasts
Percentage of quarters Merck's earnings beat analyst consensus—out of the last 4 reports.

When Does Merck Report Earnings?

Merck's next earnings report is scheduled for October 29, 2026, according to the company's announcement.

The expected earnings per share (EPS) is 2.13 USD. Analyst forecasts range from 1.80 to 2.29 USD. The market reacts not to the absolute earnings, but to the difference between the actual result and this forecast.

Expected revenue: 17.33 B USD.

Merck's Last Earnings Report: What the Numbers Showed

Merck's last reported quarter ended on June 30, 2026. Revenue was $16.61 billion, and net income was -$1.33 billion. EPS reached -$0.13, compared to analysts' forecast of -$0.26—beating expectations by 49.43%. The share price changed by +0.44% in the first session after the release.

Revenue
$16.61 bn
for the quarter
Net income
-$1.33 billion
for the quarter
EPS
-$0.13
estimate -0.26
Surprise
+49.43%
vs. consensus
Share price after report
+0.44%
next trading day
Net margin
-8.04%
net income to revenue

Insider Transactions: Merck

Who from the management board, supervisory board, US Congress, or government bought and sold shares of this company — based on official filings.

Insider Buys · 12 mo.
22
≈ $337K
Sales · 12 mo.
36
Unique individuals
18
in the last year
Last transaction
September 24, 2026
Latest transactionsForm 4, STOCK Act, OGE, MAR
Donald Trump
Donald Trump · Sale MRK
$250K–$500KJuly 31, 2026
Donald Trump
Donald Trump · Purchase MRK
$1K–$15KJune 23, 2026
Donald Trump
$50K–$100KJune 15, 2026
Maria Salazar
Maria Salazar · sale MRK
$1k–$15kSeptember 24, 2026
Maria Salazar
Maria Salazar · Purchase MRK
$15k–$50kAugust 19, 2026
Maria Salazar
Maria Salazar · Purchase MRK
$15k–$50kAugust 19, 2026
Chirfi Guindo · Sale MRK
$1.4M August 13, 2026
Richard R. Deluca · Sale MRK
$1.5M August 12, 2026
See insider faces on the chart in the app →

How the stock reacted to past earnings

The company beat analyst estimates in 100% of the last 4 quarters.

The average share price change on the day after earnings release is 1.65% — regardless of direction. The largest move was 4.38%. This number says more about the risk of holding a position through an earnings report than the earnings forecast itself.

Merck Share Price Reaction to EarningsBar chart: Merck share price change on the day after the last 4 earnings releases. Increased after 3 of them, decreased after 1. Largest movement: 4.38%.-0.69%X 25+4.38%Feb 26+1.09%Q26+0.44%Aug 26
Merck share price change on the day after the earnings report release. Green bar indicates an increase, red indicates a decrease.
EPS Forecast vs. Actual — MerckBar chart comparing EPS forecasts with Merck's actual results over the last 4 quarters. Results were higher than forecast in 4 of them.2.352.58Q3 252.012.04Q4 25-1.47-1.28Q1 26-0.26-0.13Q2 26analyst forecastCompany earnings
Merck's EPS: analyst forecast and actual result, in USD.
Merck Quarterly Earnings — Forecast, Actuals, and Share Price Reaction After Publication. EPS in USD.
QuarterRelease dateEPS estimateActual EPSSurpriseShare price reaction
June 30, 2026August 4, 2026-0.26-0.13+49.43%+0.44%
March 31, 2026April 30, 2026-1.47-1.28+13.15%+1.09%
December 31, 2025February 3, 20262.012.04+1.47%+4.38%
September 30, 2025October 30, 20252.352.58+9.85%-0.69%

How much this company's stock moves after earnings

Merck's share price changes by an average of 1.65% on the first trading day after earnings releases, based on the last 4 reports, regardless of direction. This ranks 172 out of 180 companies for which we calculated this statistic.

Analyst forecasts for upcoming periods

The consensus is the average of many analysts' forecasts. The more analysts behind a number, the less likely it is to be a single error—but forecast agreement is never a guarantee of the actual result.

Merck Forecasts — EPS in USD.
PeriodEPS estimateEPS a year agoChangeRevenue forecastAnalysts
Current quarter2.132.58-17.59%$17.33 bn18
Next quarter1.952.04-4.35%$16.80 bn18
Current year2.698.98-70.07%$67.08 bn26
Next year9.322.69+246.78%$70.02 bn25

Revenue and margins quarter by quarter

Margin shows how much of sales a company retains. Rising revenue with shrinking margins means growth is coming at the expense of profitability—and that's usually more interesting than sales growth alone.

Merck Revenue and MarginBar chart of Merck's quarterly revenue for the last 5 quarters; revenue is growing, with the net margin overlaid as a line.Q2 25Q3 25Q4 25Q1 26Q2 2628.01%33.49%18.07%-26.03%-8.04%Quarterly revenueNet margin
Merck quarterly revenue in USD and net margin for the same quarter.
Merck Income Statement, Quarterly.
QuarterRevenueGross marginOperating marginNet margin
June 30, 2026$16.61 bn73.54%-2.61%-8.04%
March 31, 2026$16.29 bn74.24%-19.65%-26.03%
December 31, 2025$16.40 bn66.15%24.79%18.07%
September 30, 2025$17.28 bn77.69%37.94%33.49%
June 30, 2025$15.81 bn77.50%35.13%28.01%

Merck Dividend

The last ex-dividend date was September 15, 2026. The date of the next payment is not yet known — it depends on the resolution of the general meeting, and Yahoo only provides the date after it is announced.

Note: The payout ratio is 266.67%, meaning Merck paid out more than it earned—from savings, debt, or a one-time gain. Such a dividend may not be repeated next year.

Dividend Yield
2.39%
from the last payment
Per Share
3.40 USD
annually
Payout Ratio
266.67%
portion of profit returned to shareholders
Ex-dividend date
September 15, 2026
last known

Who Reports in the Coming Weeks

Dates from the Portevo calendar — companies in the same industry are listed first, as their earnings often move the share prices of their peers even before their own reports.

About Merck

Merck & Co., Inc. is listed on the New York Stock Exchange under the ticker MRK, and its headquarters are in the United States. The company belongs to the Healthcare sector (industry: Drug Manufacturers - General).

  • Ticker: MRK
  • Exchange: New York Stock Exchange
  • Trading Currency: USD
  • Sector: healthcare
  • Number of Analysts Providing Estimates: 25
  • 52-Week Range: 82.01 – 156.92
  • Company Website: https://www.merck.com

Frequently Asked Questions

When does Merck release earnings?

The next report is scheduled for October 29, 2026.

What were Merck's results last quarter?

For the quarter ended June 30, 2026: revenue 16.61 billion USD, net income -1.33 billion USD, EPS -0.13 USD. This is +49.43% compared to analyst forecasts.

What is Merck's ticker symbol?

MRK — on the New York Stock Exchange. You may also see MRK on quote services.

What is the EPS forecast for Merck?

The analyst consensus for the upcoming quarter is $2.13 per share. Individual forecasts range from $1.80 to $2.29.

How much does Merck's share price usually change after earnings?

On average, 1.65% in the session after publication, counting both directions. The largest recorded movement was 4.38%.

Does Merck usually beat analyst forecasts?

In the last 4 quarters, results exceeded forecasts in 100% of cases. History does not predict the next report, but it shows how cautiously analysts approach this company.

Where can I check Merck's financial results in English?

On Portevo — the earnings calendar, analyst forecasts, surprise history, and share price reactions are available for free and without an account.

Other companies in the healthcare sector

A company's earnings are most informative when compared to competitors in the same industry — this shows whether a weak quarter was a company-specific issue or a market-wide trend.

Related

Track Merck on Portevo

The company page in the app includes a price chart, indicators, and industry comparisons. Add a company to your watchlist, and its report will be highlighted in the earnings calendar—along with the rest of your portfolio.

Portevo is not an investment advisor. The data and analyses are for informational and educational purposes only and do not constitute a recommendation or an offer to buy or sell financial instruments. Quotes are from external providers and may be delayed. You make investment decisions at your own risk.

Portevo App

Your entire portfolio, company earnings, and insider trades in one place

Upload your XTB report or add companies manually — Portevo will calculate your net profit after costs, show you the earnings dates for your companies, and display insider faces on charts.

  • Portfolio with Net Profit After Costs
  • Earnings Calendar for Your Companies
  • Pelosi, Trump, and CEO Trades on a Chart
  • Works in Browser and on iPhone

No credit card required. A demo portfolio is available immediately; create your own by uploading a report.

Portevo Portfolio: Value, Net Performance, and ChartCompany Earnings Calendar in the Portevo AppETF Fact Sheet with Quotes in PortevoTransaction History and Portfolio Tracking in Portevo
Portevo — free portfolio, earnings, and insider tradesOpen App